Industry
Biotechnology
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
December 13, 2023 | 1:29 pm
Portfolio Pulse from Benzinga Insights
November 20, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
November 17, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
November 13, 2023 | 10:04 pm
Portfolio Pulse from Benzinga Newsdesk
August 25, 2023 | 12:04 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2023 | 8:33 pm
Portfolio Pulse from Benzinga Insights
August 04, 2023 | 6:06 pm
Portfolio Pulse from Benzinga Newsdesk
August 04, 2023 | 10:28 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.